Diffuse coronary artery disease is a subtype of coronary artery disease (CAD) in which larger sections of coronary arteries have a high plaque buildup. It is less common than focal CAD and can be more ...

Disease pattern is a strong modifier of how much PCI will reduce angina and may explain prior negative trials in this space.

Modeyso is the first FDA-approved systemic therapy for H3 K27M-mutant diffuse midline glioma, targeting both adult and pediatric patients. Clinical trials demonstrated a 22% overall response rate with ...

Diffuse optical techniques have proven to be valuable methods for non-invasively observing blood flow in living subjects. A number of modalities have been developed, with diffuse correlation ...

It is, I believe, generally recognized that collaboration among funders is important, because none of us has the resources to make serious inroads on big problems by ourselves. Yet despite widespread ...

In the article that accompanies this editorial, Bartlett et al 11 present the results of ECHELON-3, a phase III trial comparing brentuximab vedotin + lenalidomide + rituximab (BV + Len + R) with ...